Alethea Capital Management, LLC logo

Alethea Capital Management, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Alethea Capital Management, LLC with $155.4M in long positions as of Q3 2025, 74% allocated to Healthcare, and 94% concentrated in top 10 positions.

Portfolio Value
$155.4M
Top 10 Concentration
94%
Top Sector
Healthcare (74%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 74.10%HealthcareETF: 20.20%ETFUtilities: 1.30%Real Estate: 1.30%Consumer Defensive: 0.90%Consumer Cyclical: 0.60%Communication Services: 0.60%Industrials: 0.50%Energy: 0.20%
Healthcare
74.10%
ETF
20.20%
Utilities
1.30%
Real Estate
1.30%
Consumer Defensive
0.90%
Consumer Cyclical
0.60%
Communication Services
0.60%
Industrials
0.50%
Energy
0.20%

Industry Breakdown

20 industries across all sectors

Biotechnology: 73.33%BiotechnologyETF: 20.15%ETFRegulated Electric: 1.01%REIT - Residential: 0.60%Telecommunications Services: 0.56%Drug Manufacturers - General: 0.40%14 more: 3.55%
Biotechnology
Healthcare
73.33%
ETF
ETF
20.15%
Regulated Electric
Utilities
1.01%
REIT - Residential
Real Estate
0.60%
Telecommunications Services
Communication Services
0.56%
Drug Manufacturers - General
Healthcare
0.40%
REIT - Healthcare Facilities
Real Estate
0.36%
Medical - Healthcare Plans
Healthcare
0.36%
Packaged Foods
Consumer Defensive
0.36%
Restaurants
Consumer Cyclical
0.34%
Regulated Water
Utilities
0.33%
Beverages - Alcoholic
Consumer Defensive
0.31%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 1.50%Large Cap ($10B - $200B): 4.33%Mid Cap ($2B - $10B): 65.89%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 8.04%Micro Cap ($50M - $300M): 0.02%N/A (ETF or Unknown): 20.22%N/A (ETF or Unknown)
Mega Cap (> $200B)
1.50%
Large Cap ($10B - $200B)
4.33%
Mid Cap ($2B - $10B)
65.89%
Small Cap ($300M - $2B)
8.04%
Micro Cap ($50M - $300M)
0.02%
N/A (ETF or Unknown)
20.22%

Portfolio Concentration

Top 10 Holdings %
94.46%
Top 20 Holdings %
97.72%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
99.97%
International
0.027%
Countries
2
Largest Int'l Market
Canada - 0.03%
United States of America
99.97% ($155.3M)
32 holdings
Canada
0.03% ($42.3K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
11.7 quarters
Avg. Top 20
5.9 quarters
Avg. All Positions
5.2 quarters
Median Holding Period
0 quarters
Persistence Rate
27.27%
Persistent Holdings Weight
93.32%
Persistent Positions
9
Longest Held
Cidara Therapeutics, Inc. logo
Cidara Therapeutics, Inc.CDTX - 31 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.32%
Avg. Position Weight
3.03%
Largest Position
Axsome Therapeutics, Inc logo
Axsome Therapeutics, IncAXSM - 52.44%

Historical (Since Q4 2014)

Avg. New Position
1.53%
Largest Position
Axsome Therapeutics, Inc logo
Axsome Therapeutics, IncAXSM - 70.10% (Q4 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
7.3%
Value Traded
$11.39M
Positions Added
3
Positions Exited
20

Historical (Since Q4 2014)

Avg. Turnover Ratio
30.6%
Avg. Positions Added
11
Avg. Positions Exited
24
Highest Turnover
73.1%
Q1 2015
Lowest Turnover
4.0%
Q4 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.